The research activities of the European Research Initiative on CLL (ERIC)
What leads to shorter progression-free survival in CLL patients?
Factors to consider in frontline and relapsed CLL before treatment
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia
The CLL2-BAG trial: can CLL patients safely cease treatment after remission?